SKELLY WILLIAM G has filed 6 insider transactions across 1 company since January 2024.
Most recent transaction: a option exercise of 50000 shares of ACURA PHARMACEUTICALS, INC ($ACUR) on January 02, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2025 | ACURA PHARMACEUTICALS, INC | $ACUR | SKELLY WILLIAM G | Director | M | Common Stock | 50000 | $0.00 | 625,989.0000 | 56,801,000 | 8.68% | 0.09% |
| Jan. 2, 2025 | ACURA PHARMACEUTICALS, INC | $ACUR | SKELLY WILLIAM G | Director | M | Restricted Stock Units (2021 Plan) | 50000 | $0.00 | 0.0000 | 56,801,000 | 100.00% | 0.09% |
| Jan. 2, 2025 | ACURA PHARMACEUTICALS, INC | $ACUR | SKELLY WILLIAM G | Director | A | Restricted Stock Units (2021 Plan) | 50000 | $0.00 | 50,000.0000 | 56,801,000 | 50.00% | 0.09% |
| Jan. 2, 2024 | ACURA PHARMACEUTICALS, INC | $ACUR | SKELLY WILLIAM G | Director | M | Common Stock | 50000 | $0.00 | 575,989.0000 | 56,801,000 | 9.51% | 0.09% |
| Jan. 2, 2024 | ACURA PHARMACEUTICALS, INC | $ACUR | SKELLY WILLIAM G | Director | M | Restricted Stock Units (2021 Plan) | 50000 | $0.00 | 0.0000 | 56,801,000 | 100.00% | 0.09% |
| Jan. 2, 2024 | ACURA PHARMACEUTICALS, INC | $ACUR | SKELLY WILLIAM G | Director | A | Restricted Stock Units (2021 Plan) | 50000 | $0.00 | 50,000.0000 | 56,801,000 | 50.00% | 0.09% |